|
TIGD7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.330200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.094400E-01 |
| Normal-vs-Stage2 |
4.244200E-01 |
| Normal-vs-Stage3 |
1.738630E-03 |
| Normal-vs-Stage4 |
1.404230E-01 |
| Stage1-vs-Stage2 |
6.957600E-01 |
| Stage1-vs-Stage3 |
6.999500E-03 |
| Stage1-vs-Stage4 |
3.180800E-01 |
| Stage2-vs-Stage3 |
1.674420E-01 |
| Stage2-vs-Stage4 |
6.698600E-01 |
| Stage3-vs-Stage4 |
3.407200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.026050E-01 |
| Normal-vs-AfricanAmerican |
1.059760E-02 |
| Normal-vs-Asian |
5.716800E-01 |
| Caucasian-vs-AfricanAmerican |
9.965600E-02 |
| Caucasian-vs-Asian |
7.414600E-01 |
| AfricanAmerican-vs-Asian |
8.163800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.997200E-03 |
| Normal-vs-Female |
8.314600E-01 |
| Male-vs-Female |
1.241680E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.084600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.782440E-01 |
| Normal-vs-Age(61-80Yrs) |
4.058200E-02 |
| Normal-vs-Age(81-100Yrs) |
7.204500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.809000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.811000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.440400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.997600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.147800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.915200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.569400E-01 |
| Normal-vs-Grade 2 |
9.825200E-01 |
| Normal-vs-Grade 3 |
3.984500E-03 |
| Normal-vs-Grade 4 |
2.164700E-03 |
| Grade 1-vs-Grade 2 |
4.473800E-01 |
| Grade 1-vs-Grade 3 |
5.238300E-02 |
| Grade 1-vs-Grade 4 |
3.306400E-02 |
| Grade 2-vs-Grade 3 |
3.504200E-03 |
| Grade 2-vs-Grade 4 |
1.361210E-03 |
| Grade 3-vs-Grade 4 |
1.854850E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.184400E-01 |
| Normal-vs-ccB subtype |
4.32190000000388E-05 |
| ccA subtype-vs-ccB subtype |
7.63069999965005E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.488500E-02 |
| Normal-vs-N1 |
4.621000E-01 |
| N0-vs-N1 |
8.647400E-01 |
|
|
